DBVT Q4 2019 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-61.0% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$46M-2740.8% margin

Net Income

-$47M-2838.6% margin

EPS (Diluted)

$-5.20

QoQ Revenue Growth

-39.3%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$31M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$272M

Total Liabilities

$79M

Stockholders' Equity

$193M

Cash & Equivalents

$193M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$4M	-61.0%
Gross Profit	$2M	$4M	-61.0%
Operating Income	-$46M	-$56M	+17.9%
Net Income	-$47M	-$56M	+14.6%